SEC 13F Intelligence

Trails Edge Capital Partners, LP / APGE

Trails Edge Capital Partners, LP’s Apogee Therapeutics Inc Position

Does Trails Edge Capital Partners, LP own Apogee Therapeutics Inc (APGE)? Not currently — the last reported position was 192.0K shares worth $14M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$14M
Q4 2025
Shares
192.0K
% of Portfolio
+3.58%
Quarters Held
1
position exited

Position History APGE

Reported value by quarter
Q4 ’25: $14MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2025192.0K$14M+3.58%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trails Edge Capital Partners, LP’s full portfolio or all institutional holders of APGE.